Open Access
Issue
SICOT-J
Volume 7, 2021
Article Number 49
Number of page(s) 7
Section Knee
DOI https://doi.org/10.1051/sicotj/2021049
Published online 14 September 2021
  • Turcotte RE (2006) Giant cell tumor of bone. Orthop Clin North Am. 37(1), 35–51. [PubMed] [Google Scholar]
  • Mavrogenis AF, Igoumenou VG, Megaloikonomos PD, Panagopoulos GN, Papagelopoulos PJ, Soucacos PN (2017) Giant cell tumor of bone revisited. SICOT-J 3, 54. [PubMed] [Google Scholar]
  • Roberts P, Chan D, Grimer RJ, Sneath RS, Scales JT (1991) Prosthetic replacement of the distal femur for primary bone tumours. J Bone Joint Surg Br 73(5), 762–769. [PubMed] [Google Scholar]
  • Kamal AF, Rubiansyah P (2019) Clinical outcome of various limb salvage surgeries in osteosarcoma around knee: Megaprosthesis, extracorporeal irradiation and resection arthrodesis. Ann Med Surg 42, 14–18. [Google Scholar]
  • Mittermayer F, Krepler P, Dominkus M, Schwameis E, Sluga M, Heinzl H, Kotz R (2001) Long-term followup of uncemented tumor endoprostheses for the lower extremity. Clin Orthop Relat Res 388, 167–177. [Google Scholar]
  • Biau D, Faure F, Katsahian S, Jeanrot C, Tomeno B, Anract P (2006) Survival of total knee replacement with a megaprosthesis after bone tumor resection. J Bone Joint Surg Am 88(6), 1285–1293. [PubMed] [Google Scholar]
  • Natarajan MV, Sivaseelam A, Rajkumar G, Hussain SH (2003) Custom megaprosthetic replacement for proximal tibial tumours. Int Orthop 27(6), 334–337. [PubMed] [Google Scholar]
  • Henderson ER, Groundland JS, Pala E, et al. (2011) Failure mode classification for tumor endoprostheses: retrospective review of five institutions and a literature review. Journal of Bone and Joint Surgery American 93(5), 418–429. [Google Scholar]
  • Kivioja AH, Blomqvist C, Hietaniemi K, et al. (2008) Cement is recommended in intralesional surgery of giant cell tumors: A Scandinavian Sarcoma Group study of 294 patients followed for a median time of 5 years. Acta Orthop 79(1), 86–93. [PubMed] [Google Scholar]
  • Fraquet N, Faizon G, Rosset P, et al (2009) Long bones giant cells tumors: Treatment by curretage and cavity filling cementation. Orthop Traumatol Surg Res 95(6), 402–406. [PubMed] [Google Scholar]
  • Saikia KC, Bhattacharyya TD, Bhuyan SK, Bordoloi B, Durgia B, Ahmed F. 2011. Local recurrences after curettage and cementing in long bone giant cell tumor. Indian J Orthop 45(2), 168–173. [PubMed] [Google Scholar]
  • Gao ZH, Yin JQ, Xie XB, et al. (2014) Local control of giant cell tumors of the long bone after aggressive curettage with and without bone cement. BMC Musculoskelet Disord 15, 330. [PubMed] [Google Scholar]
  • Enneking WF, Dunham W, Gebhardt MC, Malawar M, Pritchard DJ (1993) A system for the functional evaluation of reconstructive procedures after surgical treatment of tumors of the musculoskeletal system. Clin Orthop Relat Res 286, 241–246. [Google Scholar]
  • Glasser D, Langlais F (1991) The ISOLS radiological implant evaluation system. In: Limb Salvage: Major Reconstructions in Oncologic and Nontumoral Conditions. Langlais F, Tomeno B, Editors. Heidelberg, Germany, Springer-Verlag. [Google Scholar]
  • Trieb K, Bitzan P, Lang S, Dominkus M, Kotz R (2001) Recurrence of curetted and bone-grafted giant-cell tumours with and without adjuvant phenol therapy. Eur J Surg Oncol 27(2), 200–202. [PubMed] [Google Scholar]
  • Singh VA, Puri A (2020) The current standing on the use of Denosumab in giant cell tumour of the bone. J Orthop Surg 28(3), 2309499020979750. [Google Scholar]
  • Kulkarni AG, Patel A (2019) Denosumab: A potential new treatment option for recurrent Aneurysmal Bone Cyst of the spine. SICOT-J 5, 10. [CrossRef] [EDP Sciences] [PubMed] [Google Scholar]
  • Singaravadivelu V, Kavinkumar V (2020) Giant cell tumour around knee managed by curettage and zoledronic acid with structural support by fibula cortical struts. Malays Orthop J 14(3), 42–49. [PubMed] [Google Scholar]
  • Campanacci M, Capanna R, Fabbri N, Bettelli G (1990) Curettage of giant cell tumor of bone. Reconstruction with subchondral grafts and cement. Chir Organi Mov 75(1 Suppl), 212–213. [PubMed] [Google Scholar]
  • Saibaba B, Chouhan DK, Kumar V, Dhillon MS, Rajoli SR (2014) Curettage and reconstruction by the sandwich technique for giant cell tumours around the knee. J Orthop Surg (Hong Kong) 22(3), 351–355. [PubMed] [Google Scholar]
  • Prosser GH, Baloch KG, Tillman RM, Carter SR, Grimer RJ (2005) Does curettage without adjuvant therapy provide low recurrence rates in giant cell tumors of bone? Clin Orthop Relat Res 435, 211–218. [Google Scholar]
  • Gouin F, Dumaine V (2013) French Sarcoma and Bone Tumor Study Groups GSF-GETO. Local recurrence after curettage treatment of giant cell tumors in peripheral bones: retrospective study by the GSF-GETO (French Sarcoma and Bone Tumor Study Groups). Orthop Traumatol Surg Res 99(6 Suppl), S313–S318. [PubMed] [Google Scholar]
  • Klenke FM, Wenger DE, Inwards CY, Rose PS, Sim FH (2011) Giant cell tumor of bone: risk factors for recurrence. Clin Orthop Relat Res 469(2), 591–599. [PubMed] [Google Scholar]
  • Wada T, Kaya M, Nagoya S, et al. (2002) Complications associated with bone cementing for the treatment of giant cell tumors of bone. J Orthop Sci 7(2), 194–198. [PubMed] [Google Scholar]
  • Mjöberg B, Pettersson H, Rosenqvist R, Rydholm A (1984) Bone cement, thermal injury and the radiolucent zone. Acta Orthop Scand 55(6), 597–600. [PubMed] [Google Scholar]
  • O’Donnell RJ, Springfield DS, Motwani HK, Ready JE, Gebhardt MC, Mankin HJ (1994) Recurrence of giant-cell tumors of the long bones after curettage and packing with cement. J Bone Joint Surg Am 76(12), 1827–1833. [PubMed] [Google Scholar]
  • Van der Heijden L, Dijkstra PD, Campanacci DA, Gibbons CL, van de Sande MA (2013) Giant cell tumor with pathologic fracture: Should we curette or resect? Clin Orthop Relat Res 471(3), 820–829. [PubMed] [Google Scholar]